文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

肺栓塞与心源性休克接受体外膜氧合患者的长期随访与生活质量

Long-term follow-up and quality of life in patients receiving extracorporeal membrane oxygenation for pulmonary embolism and cardiogenic shock.
PubMed 文献 · Ann Intensive Care · 2021-12-24
一句话结论严重难治性肺栓塞伴心源性休克甚至CPR中接受ECMO的幸存者长期似乎恢复良好,生活质量可接受、心肺功能仅轻度受限。

该研究纳入2007至2020年因急性肺栓塞合并严重心源性休克或需机械复苏而接受静脉-动脉或静脉-静脉ECMO的119例患者,通过电话和面谈获取幸存者长期数据,随访内容包括EQ-5D-5L生活质量问卷、超声心动图、肺功能测试和心肺运动试验。出院存活率为45.4%(54/119),随访期间9例死亡;中位随访54.5个月(25-73;56±38个月)时34例回答了生活质量问卷,EQ5D5L指数较德国参考人群轻度降低(0.7±0.3 vs. 0.9±0.04;p<0.01)。25例(73.5%)无活动受限,22例(65%)能处理日常活动,10例(29.4%)表达焦虑和抑郁,33.3%恢复工作(平均每周工作36.2±12.5小时),15例(45.4%)提前退休。12例(35.3%)表达运动耐量受限和呼吸困难;59%(20/34)接受超声心动图和肺功能测试,50%(17/34)接受心肺运动试验,未见右心室功能相关损害,平均峰值摄氧量仅轻度降低(预计值的76.3%)。作者认为这些结果需通过更大研究队列的进一步研究加以证实。

要点

  • 119例急性肺栓塞合并严重心源性休克或需机械复苏者接受静脉-动脉或静脉-静脉ECMO,出院存活率45.4%(54/119)。
  • 中位随访54.5个月(25-73;56±38个月)时34例完成EQ-5D-5L问卷,EQ5D5L指数0.7±0.3,德国参考人群0.9±0.04(p<0.01)。
  • 幸存者中25例(73.5%)无活动受限,22例(65%)能处理日常活动,10例(29.4%)表达焦虑和抑郁。
  • 33.3%恢复工作(平均每周36.2±12.5小时),15例(45.4%)提前退休;12例(35.3%)表达运动耐量受限和呼吸困难。
  • 接受检查者中未见右心室功能相关损害,平均峰值摄氧量为预计值的76.3%;作者认为需更大队列进一步研究证实。

适用人群与场景

  • 2007至2020年因急性肺栓塞合并严重心源性休克或需机械复苏(CPR)而接受静脉-动脉或静脉-静脉ECMO的119例患者。
  • 多数患者(n=80,67%)在CPR期间或之后恢复自主循环时置入ECMO。

研究设计与关键结果

  • 研究类型为2007至2020年单中心(原文未写中心数,不补)长期随访研究,纳入119例急性肺栓塞合并严重心源性休克或需机械复苏并接受静脉-动脉或静脉-静脉ECMO的患者。
  • 出院存活率为45.4%(54/119),随访期间9例死亡。
  • 中位随访54.5个月(25-73;56±38个月)时34例回答了生活质量问卷。
  • EQ5D5L指数为0.7±0.3,德国参考人群为0.9±0.04,差异有统计学意义(p<0.01)。
  • 25例(73.5%)无活动受限,22例(65%)能处理日常活动,10例(29.4%)表达焦虑和抑郁。
  • 33.3%恢复工作(平均每周工作36.2±12.5小时),15例(45.4%)提前退休。
  • 12例(35.3%)表达运动耐量受限和呼吸困难;59%(20/34)接受超声心动图和肺功能测试,50%(17/34)接受心肺运动试验;未见右心室功能相关损害,平均峰值摄氧量为预计值的76.3%。

证据类型、等级与局限

  • 局限:作者指出需通过更大研究队列的进一步研究来证实这些结果。

对床旁实践的改变

  • 作者认为,严重难治性肺栓塞伴心源性休克甚至CPR中接受ECMO的幸存者长期似乎恢复良好,生活质量可接受、心肺功能仅轻度受限。

指南或共识出处

  • 自2019年起,欧洲指南推荐考虑将体外生命支持作为急性高危肺栓塞伴循环衰竭或心脏骤停的挽救治疗策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Since 2019, European guidelines recommend considering extracorporeal life support as salvage strategy for the treatment of acute high-risk pulmonary embolism (PE) with circulatory collapse or cardiac arrest. However, data on long-term survival, quality of life (QoL) and cardiopulmonary function after extracorporeal membrane oxygenation (ECMO) are lacking.

METHODS: One hundred and nineteen patients with acute PE and severe cardiogenic shock or in need of mechanical resuscitation (CPR) received venoarterial or venovenous ECMO from 2007 to 2020. Long-term data were obtained from survivors by phone contact and personal interviews. Follow-up included a QoL analysis using the EQ-5D-5L questionnaire, echocardiography, pulmonary function testing and cardiopulmonary exercise testing.

RESULTS: The majority of patients (n = 80, 67%) were placed on ECMO during or after CPR with returned spontaneous circulation. Overall survival to hospital discharge was 45.4% (54/119). Nine patients died during follow-up. At a median follow-up of 54.5 months (25-73; 56 ± 38 months), 34 patients answered the QoL questionnaire. QoL differed largely and was slightly reduced compared to a German reference population (EQ5D5L index 0.7 ± 0.3 vs. 0.9 ± 0.04; p < 0.01). 25 patients (73.5%) had no mobility limitations, 22 patients (65%) could handle their activities, while anxiety and depression were expressed by 10 patients (29.4%). Return-to-work status was 33.3% (average working hours: 36.2 ± 12.5 h/per week), 15 (45.4%) had retired from work early. 12 patients (35.3%) expressed limited exercise tolerance and dyspnea. 59% (20/34) received echocardiography and pulmonary function testing, 50% (17/34) cardiopulmonary exercise testing. No relevant impairment of right ventricular function and an only slightly reduced mean peak oxygen uptake (76.3% predicted) were noted.

CONCLUSIONS: Survivors from severe intractable PE in cardiogenic shock or even under CPR with ECMO seem to recover well with acceptable QoL and only minor cardiopulmonary limitations in the long term. To underline these results, further research with larger study cohorts must be obtained.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Stadlbauer A, Philipp A, Blecha S, et al. Long-term follow-up and quality of life in patients receiving extracorporeal membrane oxygenation for pulmonary embolism and cardiogenic shock. Ann Intensive Care. 2021. PMID: 34951692. doi:10.1186/s13613-021-00975-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。